Jan 15, 2020

Federal mandate for publishing clinical trials wasn't enforced

Illustration: Rebecca Zisser/Axios

Federal officials are doing little or nothing to enforce a 2017 law that requires drugmakers and researchers to log their clinical trials into a federal database, according to an investigation published in Science.

Why it matters: The law was designed to give the public, along with outside researchers, more access to information about drugs' safety and efficacy.

The findings: Researchers failed to comply with these disclosure mandate about 55% of the time, leaving the results of 4,700 trials unpublished.

  • "Missing or late results offer potentially vital information for the most desperate patients," Science's Charles Piller writes.

Go deeper: Drugmakers opt to mine medical data in lieu of lengthy clinical trials

Go deeper

Vaccine candidate for coronavirus on track for human trials in April

A scientist is at work in the VirPath university laboratory as they try to find an effective treatment against 2019-nCoV. Photo: Jeff Pachoud/AFP via Getty Images

The National Institutes of Health and biotech company Moderna, one of several companies working to develop treatment for the novel coronavirus, are on track for human clinical trials for a vaccine in two and half months, National Institute of Allergy and Infectious Diseases director Anthony Fauci, said in a press briefing Friday.

Why it matters: If the trials prove effective, the vaccine could help protect people from future outbreaks. The researchers were able to successfully take the virus's genetic code and express proteins for animal trials. ā€œIā€™m happy to tell you there are no glitches so far," Fauci said.

Go deeper: Billionaires and multinationals donate to fight coronavirus

HHS' pending data-sharing rules spark fight over patient records

Alex Azar, secretary of HHS. Photo: Zach Gibson/Getty Images

There's an intense lobbying fight over Health and Human Services' pending health care data-sharing rules, Politico reports.

Between the lines: The fight involves hospitals, digital health firms and patient advocates.

Go deeperArrowJan 16, 2020

Coronavirus vaccines in development aren't a short-term cure

Coronavirus under a microscope. Photo: BSIP/UIG Via Getty Images

There are a dozen research projects underway to try to come up with a vaccine for the Chinese coronavirus, Biocentury reports.

What's new: Drug maker Sanofi Pasteur is entering the race to develop a vaccine by partnering with the U.S. Biomedical Advanced Research and Development Authority ā€” known as BARDA, the Department of Homeland Security announced Tuesday.

Go deeperArrowUpdated Feb 18, 2020 - Health